S100A14 and neoplasm: Conversely, the mRNA expression of S100A14, IL1A, CCL2, CXCL3 and CXCL5 in tumor tissues derived from S100A14-deficient mice was significantly reduced compared with those from their WT counterparts (Figure 4B).